AMENDMENT NO. 1 TO COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • November 25th, 2009 • Cyclacel Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 25th, 2009 Company Industry JurisdictionThis Amendment No. 1 to the Common Stock Purchase Agreement, dated as of November 24, 2009 (this “Amendment”), to the Common Stock Purchase Agreement dated as of December 10, 2007 (the “Purchase Agreement”) is entered into by and between Cyclacel Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), and Kingsbridge Capital Limited, an entity organized and existing under the laws of the British Virgin Islands (the “Investor”).